American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 165-172, (2003)
© 2003 American Thoracic Society
Current Epidemiology of Septic Shock
The CUB-Réa Network
Djillali Annane,
Philippe Aegerter,
Marie Claude Jars-Guincestre and
Bertrand Guidet for the CUB-Réa Network
Service de Réanimation Médicale, Hôpital Raymond Poincaré, Assistance Publique Hôpitaux de Paris, Garches; Service de Biostatistique et Informatique Médicale, Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne; Service de Réanimation Médicale, Hôpital Saint Antoine, Assistance Publique Hôpitaux de Paris, Paris; and INSERM U444, Paris, France
Correspondence and requests for reprints should be addressed to Djillali Annane, M.D., Ph.D., Service de Réanimation Médicale, Hôpital Raymond Poincaré, Faculté de Médecine Paris Ile de France Ouest, Université de Versaille Saint Quentinen-Yvelinnes, 104, Boulevard Raymond Poincaré, 92380 Garches, France. E-mail: djillali.annane{at}rpc.ap-hop-paris.fr
To update the epidemiology of septic shock we analyzed clinical, microbiologic, and outcome variables from 100,554 intensive care unit admissions on the Collège des Utilisateurs de Bases de données en Réanimation (CUB-Réa) database, collected from 22 hospitals over a 8-year period, 1993 to 2000. The overall frequency of septic shock was 8.2 per 100 admissions (i.e., 8,251 stays). It increased from 7.0 (in 1993) to 9.7 per 100 admissions (in 2000). The distribution analysis of the sites of infection and of the types of pathogens showed an increase in the rate of pulmonary infection (p = 0.001) and of multiresistant bacteria-related septic shock (p = 0.001). The crude mortality was 60.1% and declined from 62.1% (in 1993) to 55.9 (in 2000) (p = 0.001). As compared with matched intensive care unit admissions without sepsis, the excess risk of death due to septic shock was 25.7 (95% confidence interval, 24.027.3) and the matched odds ratio of death was 3.9 (95% confidence interval, 3.54.3). The frequency of septic shock is increasing with more multiresistant strains. Its crude mortality rate is decreasing, but patients with septic shock still have a high excess risk of death than critically ill patients who are nonseptic.
Key Words: sepsis epidemiologic studies casecontrol studies intensive care unit outcome
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Moore, S. T. Jacob, R. Pinkerton, P. Banura, D. B. Meya, S. J. Reynolds, N. Kenya-Mugisha, H. Mayanja-Kizza, and W. Michael Scheld for the Promoting Resource-Limit
Treatment of Severe Sepsis with Artemether-Lumefantrine Is Associated with Decreased Mortality in Ugandan Patients without Malaria
Am J Trop Med Hyg,
May 1, 2009;
80(5):
723 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Li Yumin, Chen Hao, Li Xun, Zhou Wence, He Minyan, M. Chiriva-Internati, M.S. Wachtel, and E.E. Frezza
A New Immunomodulatory Therapy for Severe Sepsis: Ulinastatin Plus Thymosin {alpha} 1
J Intensive Care Med,
January 1, 2009;
24(1):
47 - 53.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lecuyer, S. Chevret, B. Guidet, P. Aegerter, P. Martel, B. Schlemmer, and E. Azoulay
Case volume and mortality in haematological patients with acute respiratory failure
Eur. Respir. J.,
September 1, 2008;
32(3):
748 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hejblum, V. Ioos, J.-F. Vibert, P.-Y. Boelle, L. Chalumeau-Lemoine, C. Chouaid, A.-J. Valleron, and B. Guidet
A Web-Based Delphi Study on the Indications of Chest Radiographs for Patients in ICUs
Chest,
May 1, 2008;
133(5):
1107 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Fahy, M. C. Exline, M. A. Gavrilin, N. Y. Bhatt, B. Y. Besecker, A. Sarkar, J. L. Hollyfield, M. D. Duncan, H. N. Nagaraja, N. L. Knatz, et al.
Inflammasome mRNA Expression in Human Monocytes during Early Septic Shock
Am. J. Respir. Crit. Care Med.,
May 1, 2008;
177(9):
983 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Ventetuolo and M. M. Levy
Sepsis: A Clinical Update
Clin. J. Am. Soc. Nephrol.,
March 1, 2008;
3(2):
571 - 577.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Russell, K. R. Walley, J. Singer, A. C. Gordon, P. C. Hebert, D. J. Cooper, C. L. Holmes, S. Mehta, J. T. Granton, M. M. Storms, et al.
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
N. Engl. J. Med.,
February 28, 2008;
358(9):
877 - 887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Parrillo
Septic Shock -- Vasopressin, Norepinephrine, and Urgency
N. Engl. J. Med.,
February 28, 2008;
358(9):
954 - 956.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Garnacho-Montero, C. Ortiz-Leyba, I. Herrera-Melero, T. Aldabo-Pallas, A. Cayuela-Dominguez, J. A. Marquez-Vacaro, J. Carbajal-Guerrero, and J. L. Garcia-Garmendia
Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study
J. Antimicrob. Chemother.,
February 1, 2008;
61(2):
436 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer, K. Freivogel, Y. G. Weiss, J. Benbenishty, A. Kalenka, H. Forst, et al.
Hydrocortisone Therapy for Patients with Septic Shock
N. Engl. J. Med.,
January 10, 2008;
358(2):
111 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Russell
Management of Sepsis
N. Engl. J. Med.,
October 19, 2006;
355(16):
1699 - 1713.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Guidet, P. Aegerter, R. Gauzit, P. Meshaka, D. Dreyfuss, and on behalf of the CUB-Rea Study Group
Incidence and Impact of Organ Dysfunctions Associated With Sepsis
Chest,
March 1, 2005;
127(3):
942 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alberti, C. Brun-Buisson, S. Chevret, M. Antonelli, S. V. Goodman, C. Martin, R. Moreno, A. R. Ochagavia, M. Palazzo, K. Werdan, et al.
Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients
Am. J. Respir. Crit. Care Med.,
March 1, 2005;
171(5):
461 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-J. Boffa and W. J. Arendshorst
Maintenance of Renal Vascular Reactivity Contributes to Acute Renal Failure during Endotoxemic Shock
J. Am. Soc. Nephrol.,
January 1, 2005;
16(1):
117 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Annane, E. Bellissant, P. E. Bollaert, J. Briegel, D. Keh, and Y. Kupfer
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
BMJ,
August 28, 2004;
329(7464):
480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bloomfield and D. W. Noble
Editorial III: Corticosteroids for septic shock--a standard of care?
Br. J. Anaesth.,
August 1, 2004;
93(2):
178 - 180.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Roman-Marchant, C. E. A. Orellana-Jimenez, D. De Backer, C. Melot, and J.-L. Vincent
Septic Shock of Early or Late Onset: Does It Matter?
Chest,
July 1, 2004;
126(1):
173 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
239 - 253.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Giacometti, O. Cirioni, R. Ghiselli, F. Mocchegiani, G. D'Amato, R. Circo, F. Orlando, B. Skerlavaj, C. Silvestri, V. Saba, et al.
Cathelicidin Peptide Sheep Myeloid Antimicrobial Peptide-29 Prevents Endotoxin-induced Mortality in Rat Models of Septic Shock
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
187 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|